Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pacira Pharmaceuticals (PCRX)
NASDAQ:PCRX
Holding PCRX?
Track your performance easily
Pacira Pharmaceuticals (PCRX) Ownership Overview
1.55% Insiders
26.34% Mutual Funds
16.45% Other Institutional Investors
39.31% ETFs
16.36% Public Companies and
Individual Investors
The ownership structure of Pacira Pharmaceuticals (PCRX) stock is a mix of institutional, retail, and individual investors. Approximately 82.09% of the company’s stock is owned by Institutional Investors, 1.55% is owned by Insiders, and 16.36% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Aug 19, 2024 | Bigal Marcelo Director | xxxxxxxxxxxxx | $20034 |
| Aug 19, 2024 | Laura Brege Director | xxxxxxxxxxxxx | $12810 |
| Aug 14, 2024 | Michael J. Yang Director | xxxxxxxxxxxxx | $25800 |
| Aug 13, 2024 | Frank D. Lee Ceo,director | xxxxxxxxxxxxx | $99994 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $240182 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $514710 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $1112390 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $1368240 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,631,102 | Institution | 12.20% | 111,833,686 | |
| 4,808,357 | Institution | 10.41% | 95,493,970 | |
| 4,751,981 | Institution | 10.29% | 94,374,343 | |
| 3,936,196 | Institution | 8.52% | 78,172,853 | |
| 1,262,745 | Institution | 2.73% | 25,078,116 | |
| 1,048,353 | Institution | 2.27% | 20,820,291 | |
| 991,330 | Institution | 2.15% | 19,687,814 | |
| 673,569 | Institution | 1.46% | 13,377,080 | |
| 580,000 | Institution | 1.26% | 11,518,800 | |
| 529,885 | Institution | 1.15% | 10,523,516 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,936,196 | Institution | 8.52% | 78,172,853 | |
| 1,262,745 | Institution | 2.73% | 25,078,116 | |
| 1,048,353 | Institution | 2.27% | 20,820,291 | |
| 673,569 | Institution | 1.46% | 13,377,080 | |
| 529,885 | Institution | 1.15% | 10,523,516 | |
| 501,401 | Institution | 1.09% | 9,957,824 | |
| 440,027 | Institution | 0.95% | 8,738,936 | |
| 359,128 | Institution | 0.78% | 7,132,282 | |
| 329,901 | Institution | 0.71% | 6,551,834 | |
| 279,675 | Institution | 0.61% | 5,554,346 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,804,203 | Institution | 10.40% | 95,123,219 | |
| 3,011,899 | Institution | 6.52% | 59,816,314 | |
| 1,312,119 | Institution | 2.84% | 26,058,683 | |
| 1,376,593 | Institution | 2.98% | 22,851,444 | |
| 1,100,624 | Institution | 2.38% | 18,270,358 | |
| 742,752 | Institution | 1.61% | 12,329,683 | |
| 718,048 | Institution | 1.56% | 11,919,597 | |
| 474,312 | Institution | 1.03% | 9,419,836 | |
| 420,939 | Institution | 0.91% | 8,334,592 | |
| 411,907 | Institution | 0.89% | 8,180,473 |
FAQ
Who Owns Pacira Pharmaceuticals (PCRX)?
According to the latest TipRanks data, approximately 16.45% of the company's stock is held by institutional investors, 1.55% is held by insiders, and 16.36% is held by retail investors.
What percentage of Pacira Pharmaceuticals (PCRX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 16.45% of Pacira Pharmaceuticals (PCRX) stock is held by institutional investors.
What percentage of Pacira Pharmaceuticals (PCRX) stock is held by retail investors?
According to the latest TipRanks data, approximately 16.36% of Pacira Pharmaceuticals (PCRX) stock is held by retail investors.
Who owns the most shares of Pacira Pharmaceuticals (PCRX)?
iShares owns the most shares of Pacira Pharmaceuticals (PCRX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.